Possible  ||| S:0 E:9 ||| JJ
involvement  ||| S:9 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
iron-induced  ||| S:24 E:37 ||| JJ
oxidative  ||| S:37 E:47 ||| JJ
insults  ||| S:47 E:55 ||| NN
in  ||| S:55 E:58 ||| IN
neurodegeneration  ||| S:58 E:76 ||| JJ
Involvement  ||| S:76 E:88 ||| NNS
of  ||| S:88 E:91 ||| IN
iron  ||| S:91 E:96 ||| NN
in  ||| S:96 E:99 ||| IN
the  ||| S:99 E:103 ||| DT
development  ||| S:103 E:115 ||| NN
of  ||| S:115 E:118 ||| IN
neurodegenerative  ||| S:118 E:136 ||| JJ
disorders  ||| S:136 E:146 ||| NNS
has  ||| S:146 E:150 ||| VBZ
long  ||| S:150 E:155 ||| RB
been  ||| S:155 E:160 ||| VBN
suggested ||| S:160 E:169 ||| VBN
,  ||| S:169 E:171 ||| ,
and  ||| S:171 E:175 ||| CC
iron  ||| S:175 E:180 ||| NN
that  ||| S:180 E:185 ||| WDT
cannot  ||| S:185 E:192 ||| RB
be  ||| S:192 E:195 ||| VB
stored  ||| S:195 E:202 ||| VBN
properly  ||| S:202 E:211 ||| RB
is  ||| S:211 E:214 ||| VBZ
suggested  ||| S:214 E:224 ||| VBN
to  ||| S:224 E:227 ||| TO
induce  ||| S:227 E:234 ||| VB
iron  ||| S:234 E:239 ||| NN
toxicity ||| S:239 E:247 ||| NN
.  ||| S:247 E:249 ||| .
To  ||| S:249 E:252 ||| TO
enhance  ||| S:252 E:260 ||| VB
iron  ||| S:260 E:265 ||| NN
uptake  ||| S:265 E:272 ||| NNS
and  ||| S:272 E:276 ||| CC
suppress  ||| S:276 E:285 ||| JJ
iron  ||| S:285 E:290 ||| NN
storage  ||| S:290 E:298 ||| NN
in  ||| S:298 E:301 ||| IN
neurons ||| S:301 E:308 ||| NN
,  ||| S:308 E:310 ||| ,
we  ||| S:310 E:313 ||| PRP
generated  ||| S:313 E:323 ||| VBD
transgenic  ||| S:323 E:334 ||| NNS
( ||| S:334 E:335 ||| -LRB-
Tg ||| S:335 E:337 ||| NNP
)  ||| S:337 E:339 ||| -RRB-
mice  ||| S:339 E:344 ||| NNS
expressing  ||| S:344 E:355 ||| VBG
iron  ||| S:355 E:360 ||| NN
regulatory  ||| S:360 E:371 ||| JJ
protein  ||| S:371 E:379 ||| NN
2  ||| S:379 E:381 ||| CD
( ||| S:381 E:382 ||| -LRB-
IRP2 ||| S:382 E:386 ||| NNP
) ||| S:386 E:387 ||| -RRB-
,  ||| S:387 E:389 ||| ,
a  ||| S:389 E:391 ||| DT
major  ||| S:391 E:397 ||| JJ
regulator  ||| S:397 E:407 ||| NN
of  ||| S:407 E:410 ||| IN
iron  ||| S:410 E:415 ||| NN
metabolism ||| S:415 E:425 ||| NN
,  ||| S:425 E:427 ||| ,
in  ||| S:427 E:430 ||| IN
a  ||| S:430 E:432 ||| DT
neuron-specific  ||| S:432 E:448 ||| JJ
manner ||| S:448 E:454 ||| NN
.  ||| S:454 E:456 ||| .
Although  ||| S:456 E:465 ||| IN
very  ||| S:465 E:470 ||| RB
subtle ||| S:470 E:476 ||| JJ
,  ||| S:476 E:478 ||| ,
IRP2  ||| S:478 E:483 ||| NNP
was  ||| S:483 E:487 ||| VBD
expressed  ||| S:487 E:497 ||| VBN
in  ||| S:497 E:500 ||| IN
all  ||| S:500 E:504 ||| DT
regions  ||| S:504 E:512 ||| NNS
of  ||| S:512 E:515 ||| IN
brain  ||| S:515 E:521 ||| NN
examined ||| S:521 E:529 ||| VBD
.  ||| S:529 E:531 ||| .
In  ||| S:531 E:534 ||| IN
the  ||| S:534 E:538 ||| DT
Tg  ||| S:538 E:541 ||| JJ
mice ||| S:541 E:545 ||| NNS
,  ||| S:545 E:547 ||| ,
mitochondrial  ||| S:547 E:561 ||| JJ
oxidative  ||| S:561 E:571 ||| JJ
insults  ||| S:571 E:579 ||| NN
were  ||| S:579 E:584 ||| VBD
observed  ||| S:584 E:593 ||| VBN
including  ||| S:593 E:603 ||| VBG
generation  ||| S:603 E:614 ||| NN
of  ||| S:614 E:617 ||| IN
4-hydroxynonenal  ||| S:617 E:634 ||| CD
modified  ||| S:634 E:643 ||| CD
proteins ||| S:643 E:651 ||| NNS
,  ||| S:651 E:653 ||| ,
which  ||| S:653 E:659 ||| WDT
appeared  ||| S:659 E:668 ||| VBD
to  ||| S:668 E:671 ||| TO
be  ||| S:671 E:674 ||| VB
removed  ||| S:674 E:682 ||| VBN
by  ||| S:682 E:685 ||| IN
a  ||| S:685 E:687 ||| DT
mitochondrial  ||| S:687 E:701 ||| JJ
quality  ||| S:701 E:709 ||| NN
control  ||| S:709 E:717 ||| NN
protein  ||| S:717 E:725 ||| NN
Parkin ||| S:725 E:731 ||| NNP
.  ||| S:731 E:733 ||| .
Inter-crossing  ||| S:733 E:748 ||| JJ
of  ||| S:748 E:751 ||| IN
the  ||| S:751 E:755 ||| DT
Tg  ||| S:755 E:758 ||| JJ
mice  ||| S:758 E:763 ||| NNS
to  ||| S:763 E:766 ||| TO
Parkin  ||| S:766 E:773 ||| NNP
knockout  ||| S:773 E:782 ||| NN
mice  ||| S:782 E:787 ||| NNS
perturbed  ||| S:787 E:797 ||| VBD
the  ||| S:797 E:801 ||| DT
integrity  ||| S:801 E:811 ||| NN
of  ||| S:811 E:814 ||| IN
neurons  ||| S:814 E:822 ||| NN
in  ||| S:822 E:825 ||| IN
the  ||| S:825 E:829 ||| DT
substantia  ||| S:829 E:840 ||| JJ
nigra  ||| S:840 E:846 ||| NN
and  ||| S:846 E:850 ||| CC
provoked  ||| S:850 E:859 ||| JJ
motor  ||| S:859 E:865 ||| NN
symptoms ||| S:865 E:873 ||| NNS
.  ||| S:873 E:875 ||| .
These  ||| S:875 E:881 ||| DT
results  ||| S:881 E:889 ||| NNS
suggest  ||| S:889 E:897 ||| VBP
that  ||| S:897 E:902 ||| IN
a  ||| S:902 E:904 ||| DT
subtle ||| S:904 E:910 ||| JJ
,  ||| S:910 E:912 ||| ,
but  ||| S:912 E:916 ||| CC
chronic  ||| S:916 E:924 ||| JJ
increase  ||| S:924 E:933 ||| NN
in  ||| S:933 E:936 ||| IN
IRP2  ||| S:936 E:941 ||| FW
induces  ||| S:941 E:949 ||| FW
mitochondrial  ||| S:949 E:963 ||| FW
oxidative  ||| S:963 E:973 ||| FW
insults  ||| S:973 E:981 ||| FW
and  ||| S:981 E:985 ||| CC
accelerates  ||| S:985 E:997 ||| VBZ
neurodegeneration  ||| S:997 E:1015 ||| VBN
in  ||| S:1015 E:1018 ||| IN
a  ||| S:1018 E:1020 ||| DT
mouse  ||| S:1020 E:1026 ||| NN
model  ||| S:1026 E:1032 ||| NN
of  ||| S:1032 E:1035 ||| IN
Parkinson ||| S:1035 E:1044 ||| NNP
's  ||| S:1044 E:1047 ||| POS
disease ||| S:1047 E:1054 ||| NN
.  ||| S:1054 E:1056 ||| .
Thus ||| S:1056 E:1060 ||| RB
,  ||| S:1060 E:1062 ||| ,
the  ||| S:1062 E:1066 ||| DT
IRP2  ||| S:1066 E:1071 ||| NNP
Tg  ||| S:1071 E:1074 ||| NNP
may  ||| S:1074 E:1078 ||| MD
be  ||| S:1078 E:1081 ||| VB
a  ||| S:1081 E:1083 ||| DT
useful  ||| S:1083 E:1090 ||| JJ
tool  ||| S:1090 E:1095 ||| NN
to  ||| S:1095 E:1098 ||| TO
probe  ||| S:1098 E:1104 ||| VB
the  ||| S:1104 E:1108 ||| DT
roles  ||| S:1108 E:1114 ||| NNS
of  ||| S:1114 E:1117 ||| IN
iron-induced  ||| S:1117 E:1130 ||| JJ
mitochondrial  ||| S:1130 E:1144 ||| JJ
damages  ||| S:1144 E:1152 ||| NNS
in  ||| S:1152 E:1155 ||| IN
neurodegeraration  ||| S:1155 E:1173 ||| JJ
research ||| S:1173 E:1181 ||| NN
.  ||| S:1181 E:1183 ||| .
